Contact HealthDay
Tel: 203.855.1400 or E-mail

News By Specialty

Allergy
Anesthesiology
Cardiology
Cosmetic Surgery
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Practice
Gastroenterology
Geriatrics
Hematology & Oncology
HIV & AIDS
Infectious Disease
Internal Medicine
Nephrology
Neurology
Nursing
OBGYN & Women's Health
Ophthalmology
Orthopedics
Otolaryngology
Pain Management
Pathology
Pediatrics
Pharmacy
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Follow us on:

    


e-Healthcare Leadership Awards


Thiazolidinediones Tied to Lower Cancer Risk in Diabetes Patients
Pioglitazone, rosiglitazone linked to lower liver cancer risk; rosiglitazone tied to lower CRC risk
This article is older than one year and is no longer available.

Copyright © 2012 HealthDay. All rights reserved.

August 28, 2015

Archive Search

By Keyword:
By Category:
By Topic:

Related Articles

Cirrhosis in Hepatitis C More Widespread Than Thought

Longer Colonoscopy Withdrawal Time May Cut Cancer Risk

Patient Satisfaction Up for Dulaglutide Treatment in T2DM

CDC: Rates of Childhood Obesity Higher in U.S. Than Canada

FDA Issues Proposal on Lower-Cost, Generic Biotech Drugs

Blood Test Predicts Relapse in Early-Stage Breast Cancer